Evidence map›Paper›PMID 31573533›Full record

ReviewIET nanobiotechnology2019

Rise of cyborg microrobot: different story for different configuration.

Fanan Wei, Chao Yin, Jianghong Zheng, Ziheng Zhan, Ligang Yao

Abstract readReview
In one paragraph

Review in IET nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Metareview: a survey of active matter reviews.The European physical journal. E, Soft matter · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fanan WeiState Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang 110016, People's Republic of China. weifanan@fzu.edu.cn.
Chao YinSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, People's Republic of China.
Jianghong ZhengSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, People's Republic of China.
Ziheng ZhanSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, People's Republic of China.
Ligang YaoSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By integrating organic parts achieved through evolution and inorganic parts developed by human civilisation, the cyborg microrobot is rising by taking advantage of the high flexibility, outstanding energy efficiency, extremely exquisite structure in the natural components and the fine upgradability, nice controllability in the artefact parts. Compared to the purely synthetic microrobots, the cyborg microrobots, due to the exceptional biocompatibility and biodegradability, have already been utilised in in situ diagnosis, precise therapy and other biomedical applications. In this review, through a thorough summary of recent advances of cyborg microrobots, the authors categorise the cyborg microrobots into four major classes according to the configuration between biomaterials and artefact materials,

Indexed as

Biomedical TechnologyCyberneticsEquipment DesignHumansInventionsMicrotechnologyRobotics

Identifiers

PMID31573533
PMCPMC8676360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.